Combating the Opioid Crisis: Prevention and Public Health Solutions
Witnesses
The Honorable Scott Gottlieb, M.D.
Commissioner, Food and Drug Administration (FDA)
Dr. Anne Schuchat
Acting Director, Centers for Disease Control and Prevention
Dr. Christopher M. Jones, PharmD., M.P.H.
Director of the National Mental Health and Substance Use Policy Laboratory, Substance Abuse and Mental Health Services Administration
The Honorable Patrick Kennedy
Founder, The Kennedy Forum
Ms. Sue Thau
Public Policy Consultant, Community Anti-Drug Coalitions of America
Ms. Cartier Esham
Executive Vice President, Emerging Companies, Biotechnology Innovation Organization
Mr. Jeffrey Francer
Senior Vice President and General Counsel, Association for Accessible Medicines
Dr. John Holaday
Chairman and CEO, DisposeRx
Dr. Eric Strain
Director of the Center for Substance Abuse Treatment and Research, Johns Hopkins University School of Medicine
Dr. Kenneth Martz
Special Projects Consultant, Gaudenzia
Mr. Brad Bauer
Senior Vice President, Appriss Health
Dr. William Banner
Board President, American Association of Poison Control Centers
Dr. Michael Kilkenny
Physician Director, Cabell-Huntington Health Department of West Virginia
Ms. Jessica Hulsey Nickel
Founder, President, and CEO, Addiction Policy Forum
Mr. Ryan Hampton
Recovery Advocate, Facing Addiction
Ms. Carlene Deal-Smith
Peer Support Specialist, Presbyterian Medical Services
Dr. Mark Rosenberg
Chairman of Emergency Medicine and Chief Innovation Officer, St. Joseph’s Healthcare System, on behalf of American College of Emergency Physicians
Ms. Stacy Bohlen
CEO, National Indian Health Board
Ms. Alexis Horan
Vice President of Government Relations, Clean Slate Centers
Documents
- Hearing Notice
- Background Memo
- Opening Statement – Full Committee Chairman Walden
- Opening Statement – Health Subcommittee Chairman Burgess
- Document for the Record – Rep. Burgess – SAMHSA Statement
- Hearing Attendance (Day 1)
- Hearing Attendance (Day 2)
- Document for the Record – Rep. Burgess – American Academy of Neurology Statement
- Document for the Record – Rep. Burgess – American College of Obstetricians and Gynecologists Statement
- Document for the Record – Rep. Burgess – American Society of Addiction Medicine Statement
- Document for the Record – Rep. Burgess – Electronic Health Record Association Statement
- Document for the Record – Rep. Burgess – National Association of Chain Drug Stores Statement
- Document for the Record – Rep. Burgess – National Coalition on Health Care Statement on HR 3528
- Document for the Record – Rep. Burgess – National Coalition on Health Care Statement on HR 3692
- Document for the Record – Rep. Burgess – Ohio State University Statement
- Document for the Record – Rep. Burgess – United South and Eastern Tribes Sovereignty Protection Fund Statement
- Document for the Record – Rep. Burgess – Addiction Medicine Foundation Statement on HR 5102
- Document for the Record – Rep. Burgess – Addiction Policy Forum Statement on HR 5102
- Document for the Record – Rep. Burgess – American Academy of Addiction Psychiatry Statement on HR 5102
- Document for the Record – Rep. Burgess – American Association of Colleges of Osteopathic Medicine Statement on HR 5102
- Document for the Record – Rep. Burgess – American Nurses Association Statement on HR 5102
- Document for the Record – Rep. Burgess – American Osteopathic Association and the Massachusetts Osteopathic Society Statement on HR 5102
- Document for the Record – Rep. Burgess – Document for the Record – Rep. Burgess – American Society of Addiction Medicine Statement on HR 5102
- Document for the Record – Rep. Burgess – Association for Behavioral Healthcare Statement on HR 5102
- Document for the Record – Rep. Burgess – Coalition to Stop Opioid Overdose Statement on HR 5102
- Document for the Record – Rep. Burgess – International Certification and Reciprocity Consortium Statement on HR 5102
- Document for the Record – Rep. Burgess – Legacy Community Health Statement on HR 5102
- Document for the Record – Rep. Burgess – National Board for Certified Counselors Statement on HR 5102
- Document for the Record – Rep. Burgess – National Council for Behavioral Health Statement on HR 5102
- Document for the Record – Rep. Burgess – U.S. Representatives Clark and Rogers Statement on HR 5102
- Document for the Record – Rep. Burgess – Congressman Patrick Kennedy Hearing Testimony
- Document for the Record- Rep. Burgess – Journal of Accountable Care Article in Relation to the Mullin AINS to HR 3545
- Document for the Record- Rep. Burgess – American Journal on Addictions Article in Relation to the Mullin AINS to HR 3545
- Document for the Record- Rep. Burgess – New England Journal of Medicine Article in Relation to the Mullin AINS to HR 3545
- Document for the Record- Rep. Burgess – Journal of American Medicine Article in Relation to the Mullin AINS to HR 3545
- Document for the Record – Rep. Burgess – Ascension Michigan Article in Relation to the Mullin AINS to HR 3545
- Document for the Record – Rep. Burgess – Bloomberg Article in Relation to the Mullin AINS to HR 3545
- Document for the Record – Rep. Burgess – Congressman Patrick Kennedy Article in Relation to the Mullin AINS to HR 3545
- Document for the Record – Rep. Burgess – Health Data Management Article in Relation to the Mullin AINS to HR 3545
- Document for the Record – Rep. Burgess – National Governor Association Recommentions in Relation to the Mullin AINS to HR 3545
- Document for the Record – Rep. Burgess – President’s Commission on Combating Drug Addiction and the Opioid Crisis Draft Report in Relation to the Mullin AINS to HR 3545
- Document for the Record – Rep. Burgess – Confidentiality Coalition Statement in Support of the Mullin AINS to HR 3545
- Document for the Record – Rep. Burgess – Premier Statement in Support of the Mullin AINS to HR 3545
- Document for the Record – Rep. Burgess – America’s Essential Hospitals Statement in Support of the Mullin AINS to HR 3545
- Document for the Record – Rep. Burgess – Healthcare Leadership Council Statement in Support of the Mullin AINS to HR 3545
- Document for the Record – Rep. Burgess – Partnership to Amend Part 2 Statement in Support of the Mullin AINS to HR 3545
- Document for the Record – Rep. Lance – Opioid Infectious Diseases Coalition Statement in Support of HR __, the Eliminating Opioid-related Infectious Diseases Act
- Document for the Record – Rep. Lance – American Liver Foundation Statement in Support of HR __, the Eliminating Opioid-related Infectious Diseases Act
- Document for the Record – Rep. Lance – National Alliance of State and Territorial AIDS Directors Statement in Support of HR __, the Eliminating Opioid-related Infectious Diseases Act
- Document for the Record – Rep. Lance – National Association of County and City Health Officials Statement in Support of HR __, Eliminating Opioid-related Infectious Diseases Act
- Document for the Record – Rep. Lance – National Viral Hepatitis Roundtable Statement in Support of HR __, Eliminating Opioid-related Infectious Diseases Act
- Document for the Record – Rep. Lance – The AIDS Institute Statement in Support of HR __, Eliminating Opioid-related Infectious Diseases Act
- Document for the Record – Rep. Guthrie – Titan Pharmaceuticals Statement
- Document for the Record – Rep. Green – Campaign to Protect Patient Privacy Rights Statement
- Document for the Record – Rep. Green – Congressman Hakeem Jeffries Statement
- Document for the Record – Rep. Green – Everfi Statement
- Document for the Record – Rep. Green – National Alliance for Medication Assisted Recovery, Inc. Statement
- Document for the Record – Rep. Green – Pennsylvania Recovery Organizations Alliance Statement
- Opening Statement – Full Committee Ranking Member Pallone
- Opening Statement – Health Subcommittee Ranking Member Green
- Document for the Record – Rep. Butterfield – SAMHSA MFP Letter
- Preliminary Transcript (Day 2)
- Document for the Record – Rep. Green – Journal of Addiction Medicine Statement
- Document for the Record – Rep. Green – Rep. Kuster Statement
- Document for the Record – Rep. Green – Politico Document
- Document for the Record – Rep. Green – American Association for the Treatment of Opioid Dependence Statement
- Preliminary Transcript (Day 1)
Text of Legislation
- H.R. 449, Synthetic Drug Awareness Act
- H.R. 5002, Advancing Cutting Edge Research Act
- H.R. 5009, Jessie’s Law
- H.R. 5102, Substance Use Disorder Workforce Loan Repayment Act
- H.R. 5140, Tribal Addiction and Recovery Act
- H.R. 5176, Preventing Overdoses While in Emergency Rooms Act
- H.R. 5197, Alternatives to Opioids in the Emergency Department Act
- H.R. 5261, Treatment, Education, and Community Help to Combat Addiction Act
- H.R. 5272, Reinforcing Evidence-Based Standards Under Law in Treating Substance Abuse Act
- Discussion Draft of H.R. __, Poison Center Network Enhancement Act
- Discussion Draft of H.R. __, A Bill to Improve Fentanyl Testing and Surveillance
- Discussion Draft of H.R. __, Eliminating Opioid-Related Infectious Diseases Act
- Discussion Draft of H.R. __, Comprehensive Opioid Recovery Centers Act
- Discussion Draft of H.R. __, A Bill to Enhance and Improve State-run Prescription Drug Monitoring Programs
- Discussion Draft of H.R. __, A Bill to Support the Peer Support Specialist Workforce
- Discussion Draft of H.R. __, FDA Accelerated Approval and Breakthrough Therapy Status
- Discussion Draft of H.R. __, FDA and International Mail
- Discussion Draft of H.R. __, FDA Opioid Sparing
- Discussion Draft of H.R. __, FDA Packaging and Disposal
- Discussion Draft of H.R. __, FDA Long-term Efficacy
- Discussion Draft of H.R. __, FDA Misuse/Abuse
- H.R. 4684, Ensuring Access to Quality Sober Living Act